Related Experiment Videos
Limb-threatening necrotizing alternariosis salvaged by adjunctive hyperbaric oxygen therapy
1Department of Orthopaedic Surgery, Hyperbaric Oxygen Therapy Centre, Chang Gung Memorial Hospital, Taoyuan, Taiwan, ROC.
Scandinavian Journal of Infectious Diseases
|September 8, 1998
Summary
This study presents the first case of limb-threatening fungal infection (necrotizing alternariosis) successfully treated with hyperbaric oxygen therapy (HBO2). Adjunctive HBO2 therapy aided in salvaging limbs affected by invasive fungal infections.
Area of Science:
- Mycology
- Infectious Diseases
- Hyperbaric Medicine
Background:
- Necrotizing soft tissue infections caused by fungi, such as Alternaria, pose a significant threat, especially in immunocompromised patients.
- Standard antifungal treatments and surgical debridement may be insufficient to control invasive fungal infections.
- Hyperbaric oxygen therapy (HBO2) is an adjunctive treatment modality with potential antimicrobial and tissue-healing properties.
Observation:
- A 58-year-old immunocompromised patient with diabetes and Cushing's syndrome presented with limb-threatening necrotizing soft tissue infection of both legs caused by Alternaria.
- The infection progressed despite standard antifungal therapy and aggressive surgical debridement.
- Adjunctive hyperbaric oxygen therapy (HBO2) was initiated to manage the invasive fungal infection.
Findings:
- Hyperbaric oxygen therapy (HBO2) stabilized the invasive fungal infection, preventing further progression.
- The patient's wounds showed significant improvement and eventual healing following the adjunctive HBO2 treatment.
- This case demonstrates the successful limb salvage in necrotizing alternariosis through the use of HBO2.
Implications:
- Adjunctive hyperbaric oxygen therapy (HBO2) shows promise in treating severe, limb-threatening invasive fungal infections.
- HBO2 may potentiate host immune responses and enhance fibroblast proliferation, contributing to wound healing.
- Further research into HBO2 as an adjunctive therapy for invasive fungal infections is warranted.